A multi-centre randomised trial of cyclophosphamide versus azathioprine during remission in ANCA-associated systemic vasculitis (Cycazarem).

Registros relacionados

• Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
  por: Federica Maritati, et al.
  Publicado em: (2017-01-01)
• Efficacy and safety of belimumab and azathioprine for maintenance of remission in ANCA-associated vasculitis: a randomized controlled study
  por: Jayne, D, et al.
  Publicado em: (2019)
• Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
  por: Jones, R, et al.
  Publicado em: (2010)
• Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
  por: Frank B. Cortazar, et al.
  Publicado em: (2018-03-01)
• Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.
  por: Harper, L, et al.
  Publicado em: (2012)